Skip to main content

Consultant dermatology · UK

Eczema treatment, from emollients to biologics.

A patient guide to the modern British Association of Dermatologists and NICE pathway for atopic eczema - the topical steroid ladder, calcineurin inhibitors, phototherapy, conventional systemics, and the NICE-approved biologics and JAK inhibitors when the plan needs to go further.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What private eczema treatment costs in the UK.

Indicative ranges for the dermatology appointment, testing, phototherapy course and biologic self-pay.

In short

A consultant dermatology appointment: £250–£450, plan the same visit.

Service Indicative range
Consultant dermatology consultation £250–£450
Follow-up appointment £180–£300
Patch testing (contact dermatitis) £450–£900
Skin-prick testing (allergy) £250–£500
Narrowband UVB phototherapy (course) £1,200–£2,800
Dupilumab (Dupixent) - self-pay £1,100–£1,400 per month

Prices vary by hospital, by the consultant, by whether tests are needed, and by drug pricing.

The problem

Emollient. Steroid. Emollient. Steroid. And nothing changes.

Most adults with moderate-severe eczema have been round the same loop for years. The modern pathway is different - patch testing where relevant, calcineurin inhibitors, phototherapy, and a NICE route into biologics and JAK inhibitors when needed.

  • Sceptical about steroids?

    Used properly, matched to potency and body site, with a step-down plan - safe and effective. Left unused, uncontrolled eczema does more harm.

  • Flare, treat, flare, treat?

    Proactive maintenance with a TCI or lower-potency steroid two days a week is the standard-of-care fix - not endless rescue courses.

  • Ready for a biologic?

    If a conventional systemic has failed or is unsuitable, we build the NICE case for dupilumab, tralokinumab or a JAK inhibitor.

When it helps

When a proper dermatology plan changes the picture.

The situations we see most, plus the one red flag that means an emergency rather than an appointment.

  • Widespread atopic eczema

    Eczema affecting more than a small area - often needs phototherapy or systemic therapy rather than tubes of steroid alone.

  • Facial or eyelid eczema

    Sensitive skin sites where potent steroids are unsafe long term - where topical calcineurin inhibitors earn their place.

  • Steroid ladder not holding

    Flares returning as soon as steroid stops - the point at which maintenance TCIs, phototherapy or a biologic get considered.

  • Suspected contact dermatitis

    Eczema in an unusual pattern - hands, face, behind the ears - that may be driven by an allergen and needs patch testing.

  • Recurrent infected eczema

    Weeping, crusting flares needing repeated antibiotics - a marker that the underlying disease is not controlled.

  • Sleep, work or school being wrecked

    A high DLQI or CDLQI score is not a soft outcome - it is the score that unlocks the NICE biologic pathway.

  • Red flag: eczema herpeticum

    Sudden painful, punched-out blisters on eczematous skin, often with fever - a dermatological emergency, A&E the same day.

Treatment options

The full modern eczema ladder - in order.

What each rung on the ladder actually involves, from twice-daily emollient to biologics and JAK inhibitors.

  • Basic care - for everyone, forever

    Emollient at least twice daily, soap substitute in place of shower gel and shampoo, and honest trigger review (soap, hard water, wool, sweat).

  • Topical steroid ladder

    Mild (hydrocortisone 1%) for face and folds, moderate (Eumovate) for body flares, potent (Betnovate) for stubborn plaques, very potent (Dermovate) sparingly and never on the face - dosed in finger-tip units.

  • Topical calcineurin inhibitors

    Tacrolimus (Protopic) and pimecrolimus (Elidel) - steroid-sparing, safe for face, eyelids and flexures, and useful for weekend maintenance to prevent flares.

  • Wet wraps for flares

    A layer of emollient and topical steroid under damp tubular bandages - a paediatric mainstay for a bad flare in a child.

  • Narrowband UVB phototherapy

    Three visits a week for 8–12 weeks in a dermatology unit - a well-evidenced option for widespread eczema that has outgrown creams.

  • Conventional systemics

    Methotrexate, ciclosporin, azathioprine or mycophenolate mofetil under blood-test monitoring. Oral steroids are used only for very short rescue courses - not as maintenance.

  • Biologics - dupilumab, tralokinumab, lebrikizumab

    Injectable IL-4/IL-13 (dupilumab, licensed from 6 months) or IL-13 (tralokinumab, lebrikizumab) - NICE-approved for moderate-severe eczema when conventional systemics have failed or are unsuitable.

  • JAK inhibitors - abrocitinib, upadacitinib

    Oral Cibinqo (abrocitinib) and Rinvoq (upadacitinib) - fast, powerful, and NICE-approved via TA route. VTE, MACE and malignancy warnings mean we screen carefully and monitor closely.

Safety and red flags

The risks worth naming, honestly.

Every rung on the eczema ladder has trade-offs. Modern practice keeps them small - and knows when to escalate rather than push the same lever harder.

  • Topical steroid atrophy is real, but avoidable

    Long-term potent steroid on the same site thins the skin and causes striae. The finger-tip-unit rule and step-down to TCIs are how we prevent it.

  • Periorbital steroid needs care

    Repeated potent steroid around the eyes has been linked with glaucoma and cataract. This is exactly where tacrolimus ointment earns its keep.

  • Topical steroid withdrawal (TSW)

    A contested but real-world issue after long high-potency steroid use. We take patient reports seriously, and taper thoughtfully with TCIs and non-steroid strategies.

  • Growth in children on frequent potent steroid

    Rare but described. In a child needing potent steroid week after week, that is the trigger to escalate - not to increase the steroid.

  • Eczema herpeticum - emergency

    Painful, monomorphic, punched-out blisters on eczema skin, often with fever, is a dermatological emergency. Same-day A&E and IV aciclovir - not a creams review.

  • Secondary bacterial infection

    Golden crusting, weeping, sudden worsening - usually Staphylococcus aureus, occasionally MRSA. Swab, oral antibiotic if indicated, and bleach baths for recurrent cases.

  • Erythroderma

    Eczema covering more than 90% of the body surface is erythroderma - a medical emergency needing admission for fluid, temperature and infection management.

  • Biologic-associated conjunctivitis

    Dupilumab causes conjunctivitis in a meaningful minority. It is usually manageable with lubricants or topical steroid drops under ophthalmology guidance, not a reason to abandon the biologic.

  • JAK inhibitor cardiovascular and clot risk

    MHRA and NICE flag VTE, MACE, serious infection and malignancy warnings for JAK inhibitors, particularly over 65 or with cardiovascular risk. Screening and shared decision-making are non-negotiable.

Reading your eczema plan

Your written plan in four parts. Read the last one first.

Whichever step of the ladder you are on, the plan the dermatologist writes for you keeps to the same shape.

A UK consultant dermatologist reviewing a patient’s eczema care plan

A quiet reminder

Dermatology language is precise - “moderate potency, twice daily, one FTU per hand” - and we translate it for you.

If you would like us to talk you through the plan before your review, just ask.

  1. 01 Header

    Diagnosis, distribution, severity

    Atopic eczema versus discoid, seborrhoeic or contact dermatitis; where on the body; POEM and EASI scores; DLQI or CDLQI for impact.

  2. 02 Plan

    The written flare plan

    Which emollient, which soap substitute, which topical steroid at which strength for which body site, and how many finger-tip units per application.

  3. 03 Maintenance

    Weekend or twice-weekly maintenance

    Where a topical calcineurin inhibitor or a lower-potency steroid is used two days a week to prevent the next flare - a proactive strategy that works.

  4. 04 Escalation

    When we escalate, and to what

    Read this first: the triggers to move to phototherapy, to a conventional systemic, and - if needed - to the NICE-approved biologic or JAK pathway.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Frequently asked

Everything we get asked about eczema treatment.

Straight answers on steroids, tacrolimus, dupilumab, JAK inhibitors and when to worry.

  • Are topical steroids safe for eczema?

    Yes, when used correctly. The finger-tip-unit rule, matching potency to body site, and stepping down to topical calcineurin inhibitors or emollient-only once the flare settles keeps them safe. Uncontrolled eczema is more harmful than appropriate topical steroid use.

  • What is the difference between Protopic, Elidel and steroid cream?

    Tacrolimus (Protopic) and pimecrolimus (Elidel) are topical calcineurin inhibitors - they calm eczema without thinning the skin, which makes them well suited to the face, eyelids and skin folds and to long-term maintenance.

  • When is dupilumab (Dupixent) the right step?

    NICE TA534 recommends dupilumab for moderate-to-severe atopic eczema in adults, and later TAs extend it down to children aged six months and above, when at least one conventional systemic (ciclosporin, methotrexate, azathioprine or mycophenolate) has failed, is contraindicated or is not tolerated.

  • Are JAK inhibitors safer than biologics?

    Not necessarily. Abrocitinib (Cibinqo) and upadacitinib (Rinvoq) are powerful and fast-acting, but the MHRA class warnings on venous thromboembolism, major cardiovascular events, serious infection and malignancy mean we screen and monitor them carefully - especially over 65 or with cardiovascular risk factors.

  • What is topical steroid withdrawal (TSW)?

    A pattern of burning, redness and rebound flaring reported after long, high-potency topical steroid use - most commonly on the face. It is debated in the mainstream literature but taken seriously by dermatologists; a slow taper, generous emollient and TCIs are the usual approach.

  • Is my eczema being caused by a food?

    In infants with severe eczema an occasional food does drive flares, and skin-prick or specific IgE testing plus a supervised dietary trial is reasonable. In older children and adults, food is a much less common driver - cutting foods out on suspicion often does more harm than good.

  • How much does dupilumab cost privately in the UK?

    Self-pay costs are typically £1,100–£1,400 per month for the fortnightly injection, plus the dermatology follow-up. Many insurers cover it when the NICE criteria are met and a consultant has documented failure of a conventional systemic.

  • When should I go to A&E rather than book an appointment?

    Painful, punched-out blisters on eczematous skin (eczema herpeticum), fever with rapidly spreading redness, or eczema covering nearly the whole body (erythroderma) are dermatological emergencies. Same-day A&E, not a clinic booking.

Related

Looking for something else?